Rawstron A, Laycock-Brown G, Hale G, Davies F, Morgan G, Child J, Hillmen P, Owen R. CD52 expression patterns in myeloma and the applicability of alemtuzumab therapy. Haematologica [Internet]. 2006Nov.1 [cited 2026Nov.8];91(11):1577-8. Available from: https://haematologica.org/article/view/4226